REMS programmes are typically implemented after drug approval when the FDA determines that a medication needs to be closely ...

Following the clearance of an investigational new drug application from the FDA, a phase 1 trial will examine the novel ...

The new director at the FDA overseeing medical devices will confront criticisms about hasty approvals as she ushers in ...

GSK’s departure comes as the industry anticipates the incoming Trump administration and as it continues to grapple with the threat of the BIOSECURE Act and losses of legal challenges to the IRA’s drug ...

With the reelection of Donald Trump, we could be looking at further erosion of any semblance of oversight of supplements on ...

Drug shortages in the U.S. are increasing in number and duration, primarily affecting generic and multi-sourced drugs that ...

It’s hard to know exactly what change in Washington will mean for the health care industry starting next year. But we have ...

sided with industry when it issued its Bioengineered Food labeling regime in 2018. Trump’s USDA also relaxed school nutrition ...

Isn’t FDA Approval for Vaping Products a Good Thing? The FDA approval process has locked all manufacturers not affiliated ...

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

Trump ally Robert F. Kennedy Jr. has expressed skepticism about vaccines and vowed to restructure federal health agencies.

From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...